Cargando…
High expression of monocarboxylate transporter 4 predicts poor prognosis in patients with lung adenocarcinoma
Monocarboxylate transporter 4 (MCT-4) serves a key function in transporting lactate across the plasma membrane in various types of human cancer. Evidence indicates that MCT-4 expression is associated with non-small cell lung cancer; however, the distribution and clinical significance of MCT-4 in the...
Autores principales: | Ruan, Yushu, Zeng, Fanjun, Cheng, Zhiqiang, Zhao, Xianda, Fu, Pin, Chen, Honglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661367/ https://www.ncbi.nlm.nih.gov/pubmed/29113201 http://dx.doi.org/10.3892/ol.2017.6964 |
Ejemplares similares
-
Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma
por: Liu, Yannan, et al.
Publicado: (2019) -
High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer
por: Tong, Ying-Hui, et al.
Publicado: (2021) -
Expression of Monocarboxylate Transporter 1 in Immunosuppressive Macrophages Is Associated With the Poor Prognosis in Breast Cancer
por: Li, Bei, et al.
Publicado: (2020) -
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2011) -
Monocarboxylate transporters in cancer
por: Payen, Valéry L., et al.
Publicado: (2019)